Generation of superoxide anion radicals and platelet glutathione peroxidase activity in patients with schizophrenia

References

• CiobicaAPadurariuMDobrinIStefanescuCDobrinROxidative stress in schizophrenia – focusing on the main markersPsychiatr Danub20112323724521963690
   PubMed Web of Science ®Google Scholar
• Dietrich-MuszalskaAOlasBRabe-Jabłon´skaJOxidative stress in blood platelets from schizophrenic patientsPlatelets20051638639116236599
   PubMed Web of Science ®Google Scholar
• FendriCMechriAKhiariGOthmanAKerkeniAGahaLOxidative stress involvement in schizophrenia pathophysiology: a reviewEncephale200632244252 French16910626
   PubMed Web of Science ®Google Scholar
• LiHCChenQZMaYZhouJFImbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative studyJ Zhejiang Univ Sci B2006798198617111467
   PubMedGoogle Scholar
• MicóJARojas-CorralesMOGibert-RaholaJReduced antioxidant defense in early onset first-episode psychosis: a case-control studyBMC Psychiatry2011112621320302
   PubMed Web of Science ®Google Scholar
• RaffaMAtigFMhallaAKerkeniAMechriADecreased glutathione levels and impaired antioxidant enzyme activities in drug-naïve first-episode schizophrenic patientsBMC Psychiatry20111112421810251
   PubMed Web of Science ®Google Scholar
• ReddyRYaoJKFree radical pathology in schizophrenia: a reviewProstaglandins Leukot Essent Fatty Acids19965533438888121
   PubMed Web of Science ®Google Scholar
• YaoJKReddyROxidative stress in schizophrenia: pathogenetic and therapeutic implicationsAntioxid Redox Signal2011151999200221194354
   PubMed Web of Science ®Google Scholar
• YaoJKReddyRMcElhinnyLGvan KammenDPReduced status of plasma total antioxidant capacity in schizophreniaSchizoph Res19983218
   PubMed Web of Science ®Google Scholar
• YaoJKReddyRvan KammenDPOxidative damage and schizophreniaCNS Drugs20011528721011463134
   PubMed Web of Science ®Google Scholar
• BerkMPleinHBelshamBThe specificity of platelet glutamate receptor supersensitivity in psychotic disordersLife Sci2000662427243210894085
   PubMed Web of Science ®Google Scholar
• CamachoADimsdaleJEPlatelets and psychiatry: lessons learned from old and new studiesPsychosom Med20006232633610845346
   PubMed Web of Science ®Google Scholar
• DreuxCLaunayJMBlood platelets: neuronal model in psychiatric disordersEncephale1985115764 French2862006
   PubMedGoogle Scholar
• PleinHBerkMThe platelet as a peripheral marker in psychiatric illnessHum Psychopharmacol20011622923612404575
   PubMed Web of Science ®Google Scholar
• CarotenutoMEspositoMNutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type INeurol Sci2013341905190923532548
   PubMed Web of Science ®Google Scholar
• EspositoMRubertoMPascottoACarotenutoMNutraceutical preparations in childhood migraine prophylaxis: effects on headache outcomes including disability and behaviourNeurol Sci2012331365136822437495
   PubMed Web of Science ®Google Scholar
• IulianoLColavitaARLeoRPraticòDVioliFOxygen free radicals and platelet activationFree Radic Biol Med19972299910069034239
   PubMed Web of Science ®Google Scholar
• WachowiczBOlasBZbikowskaHMBuczyn′skiAGeneration of reactive oxygen species in blood plateletsPlatelets20021317518212180500
   PubMed Web of Science ®Google Scholar
• OlasBWachowiczBRole of reactive nitrogen species in blood platelets functionsPlatelets20071855556517852770
   PubMed Web of Science ®Google Scholar
• OlasBNowakPKolodziejczykJWachowiczBThe effects of antioxidants on peroxynitrite-induced changes in platelet proteinsThromb Res200411339940615226095
   PubMed Web of Science ®Google Scholar
• DoKQTrabesingerAHKirsten-KrügerMSchizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivoEur J Neurosci2000123721372811029642
   PubMed Web of Science ®Google Scholar
• DoKQLauerCJSchreiberWγ-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disordersJ Neurochem199565265226627595563
   PubMed Web of Science ®Google Scholar
• BerkMNgFDeanODoddSBushAIGlutathione: a novel treatment target in psychiatryTrends Pharmacol Sci20082934635118538422
   PubMed Web of Science ®Google Scholar
• DeanOGiorlandoFBerkMN-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of actionPsychiatry Neurosci2011367886
   PubMed Web of Science ®Google Scholar
• SheehanDVLecrubierYSheehanKHThe Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10J Clin Psychiatry19985922339881538
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders4th edWashingtonAmerican Psychiatric Press1994
   Google Scholar
• WachowiczBKustronJEffect of cisplatin on lipid peroxidation in pig blood plateletsCytobios19927041471511628
   PubMedGoogle Scholar
• JahnBHänschGMOxygen radical generation in human platelets: dependence on 12-lipoxygenase activity and on the glutathione cycleInt Arch Allergy Appl Immunol19909373791964932
   PubMedGoogle Scholar
• WalkowiakBMichalakEKoziolkiewiczWCierniewskiCSRapid photometric method for estimation of platelet count in blood plasma or platelet suspensionThromb Res1989567637762633404
   PubMed Web of Science ®Google Scholar
• PagliaDEValentineWNStudies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidaseJ Lab Clin Med1967701581696066618
   PubMed Web of Science ®Google Scholar
• BradfortMMA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnal Biochem197672248254942051
   PubMed Web of Science ®Google Scholar
• Dietrich-MuszalskaAOlasBThe changes of aggregability of blood platelets in schizophreniaWorld J Biol Psychiatry20091017117619514099
   PubMed Web of Science ®Google Scholar
• LapetinaEGThe signal transduction induced by thrombin in human plateletsFEBS Lett19902684004042166695
   PubMed Web of Science ®Google Scholar
• RípováDStruneckáAPlatilováVHöschlCPhosphoinositide signalling system in platelets of schizophrenic patients and the effect of neuroleptic therapyProstaglandins Leukot Essent Fatty Acids19996112512910509868
   PubMed Web of Science ®Google Scholar
• WalshMTRyanMHillmannAElevated expression of integrin alpha(IIb), beta(IIIa) in drug-naïve, first-episode schizophrenic patientsBiol Psychiatry20025287487912399140
   PubMed Web of Science ®Google Scholar
• AllebeckPSchizophrenia: a life-shortening illnessSchizophr Bull19891581892717890
   PubMed Web of Science ®Google Scholar
• AllebeckPWistedtBMortality in schizophrenia. A ten-year follow-up based on the Stockholm Country inpatient registerArch Gen Psychiatry1986436506533718167
   PubMed Web of Science ®Google Scholar
• RuschenaDMullenPEBurgessPSudden death in psychiatric patientsBr J Psychiatry19981723313369715336
   PubMed Web of Science ®Google Scholar
• RossBMPhospholipid and eicosanoid signaling disturbances in schizophreniaProstaglandins Leukot Essent Fatty Acids200369640741214623494
   PubMed Web of Science ®Google Scholar
• KulogluMUstundagBAtmacaMCanatanHTezcanAECinkilincNLipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorderCell Biochem Funct20022017111711979513
   PubMed Web of Science ®Google Scholar
• MahadikSPMukherjeeSFree radical pathology and antioxidant defence in schizophrenia: a reviewSchizoph Res199619117
   PubMed Web of Science ®Google Scholar
• RaffaMMechriAOthmanLBFendriCGahaLKerkeniADecreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patientsProg Neuropsychopharmacol Biol Psychiatry2009331178118319576938
   PubMed Web of Science ®Google Scholar
• BuckmanTDKlingASutphinMSSteinbergAEidusonSPlatelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variablesPsychiatry Res1990311141969170
   PubMed Web of Science ®Google Scholar
• NowakPOlasBBaldEGłowackiRWachowiczBPeroxynitrite-induced changes of thiol groups in human blood plateletsPlatelets20031437537914602551
   PubMed Web of Science ®Google Scholar
• BerryTA selenium transport protein model of a sub-type of schizophreniaMed Hypotheses1994434094147739414
   PubMed Web of Science ®Google Scholar
• Dietrich-MuszalskaAOlasBModification of blood platelet proteins of patients with schizophreniaPlatelets200920909619235050
   PubMed Web of Science ®Google Scholar
• MiljevicCNikolicMNikolic-KokicALipid status, anti-oxidant enzyme defence and haemoglobin content in the blood of long-term clozapine-treated schizophrenic patientsProg Neuropsychopharmacol Biol Psychiatry20103430330719962416
   PubMed Web of Science ®Google Scholar
• PadurariuMCiobicaADobrinIStefanescuCEvaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychoticsNeurosci Lett201047931732020561936
   PubMed Web of Science ®Google Scholar
• RaffaMBarhoumiSAtigFFendriCKerkeniAMechriAReduced antioxidant defense systems in schizophrenia and bipolar I disorderProg Neuropsychopharmacol Biol Psychiatry20123937137522841966
   PubMed Web of Science ®Google Scholar
• ZhangMZhaoZHeLWanCA meta-analysis of oxidative stress markers in schizophreniaSci China Life Sci20105311212420596963
   PubMed Web of Science ®Google Scholar
• Dietrich-MuszalskaAOlasBIsoprostanes as indicators of oxidative stress in schizophreniaWorld J Biol Psychiatry2007817
   Google Scholar
• BartoszGPeroxynitrite: mediator of the toxic action of nitric oxideActa Biochim Pol1996436456599104501
   PubMed Web of Science ®Google Scholar